Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11834407
APP PUB NO 20220213034A1
SERIAL NO

17306390

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to compounds that are agonists of the muscarinic M1 receptor or M1 and M4 receptors and which are useful in the treatment of muscarinic M1 or M1/M4 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds provided are of formula

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • HEPTARES THERAPEUTICS LIMITED

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Brown, Giles Albert Cambridge, GB 68 467
Congreve, Miles Stuart Cambridge, GB 128 906
Pickworth, Mark Cambridge, GB 42 340
Tehan, Benjamin Gerald Cambridge, GB 60 462

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jun 5, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 5, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 5, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00